Amphetamine abuse in Sweden: Subject demographics, changes in blood concentrations over time, and the types of coingested substances

Journal of Clinical Psychopharmacology

Volumn 33, Issue 2, 2013, Pages 248-252

  Jones, Alan Wayne ^a,b   Holmgren, Anita ^a  

^a National Board of Forensic Medicine   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

abuse; amphetamine; autopsy; blood concentrations; impaired drivers; mortality

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; CANNABIS; ILLICIT DRUG; OPIATE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUTOPSY; BLOOD SAMPLING; CANNABIS SMOKING; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUNKEN DRIVING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; SWEDEN;

ADULT; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; AUTOMOBILE DRIVING; CAUSE OF DEATH; DATABASES, FACTUAL; DRUG INTERACTIONS; FEMALE; FORENSIC TOXICOLOGY; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 84874941447     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182870310     Document Type: Article

References (24)

1. Bejerot N, Bejerot CM. Drug abuse treatment report from Sweden. Addict Dis. 1977;3:33-38.
2. Gunne LM. Effects of amphetamines in humans. In: Martin WR, ed. Handbook of Experimental Pharmacology. Berlin: Springer; 1977:247-275.
3. EMCDDA. AmphetamineVa European Union perspective in the global context. European Monitoring Centre for Drugs and Drug Addiction 2011; Available at: http://www.emcdda.europa.eu/. Accessed December 2012.
4. Holmgren P, Lindquist O. Lethal intoxications with centrally stimulating amines in Sweden 1966-1973. Z Rechtsmed. 1975;75:265-273.
5. Degenhardt L, Roxburgh A, Black E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev. 2008;27:243-252.
6. Maxwell JC, Rutkowski BA. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007. Drug Alcohol Rev. 2008;27:229-235.
7. Singleton J, Degenhardt L, Hall W, et al. Mortality among amphetamine users: a systematic review of cohort studies. Drug Alcohol Depend. 2009;105:1-8.
8. Jones AW, Holmgren A, Ahlner J. Quantitative analysis of amphetamine in femoral blood from drug-poisoning deaths compared with venous blood from impaired drivers. Bioanalysis. 2011;3:2195-2204.
9. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci. 1999;44:359-368. (Pubitemid 29131848)
10. Logan BK, Fligner CL, Haddix T. Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci. 1998;43:28-34. (Pubitemid 28063701)
11. Goldberg L. Drug abuse in Sweden. Bull Narc. 1968;20:1-31.
12. Jones AW, Holmgren A, Kugelberg FC. Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood. J Stud Alcohol Drugs. 2008;69:202-208. (Pubitemid 351878368)
13. Holmgren A, Holmgren P, Kugelberg FC, et al. High re-arrest rates among drug-impaired drivers despite zero-tolerance legislation. Accid Anal Prev. 2008;40:534-540. (Pubitemid 351329244)
14. Jones AW, Holmgren A. Concentration ratiosof methamphetamine to amphetamine in blood can help to distinguish use of methamphetamine from various mixtures of the two stimulants. J Anal Toxicol. 2012;36:634-637.
15. Logan BK. MethamphetamineVeffects on human performance and behavior. Forensic Sci Rev. 2002;14:133-151.
16. Logan BK. Amphetamines: an update on forensic issues. J Anal Toxicol. 2001;25:400-404. (Pubitemid 32656294)
17. Silber BY, Croft RJ, Downey LA, et al. The effect of D,L-methamphetamine on simulated driving performance. Psychopharmacology (Berl). 2012;219:1081-1087.
18. Silber BY, Croft RJ, Papafotiou K, et al. The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology (Berl). 2006;187:154-169. (Pubitemid 44015610)
19. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104:1085-1099.
20. Beckett AH, Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol. 1965;17:628-639.
21. Schweitzer JB, Holcomb HH. Drugs under investigation for attention-deficit hyperactivity disorder. Curr Opin Investig Drugs. 2002;3:1207-1211. (Pubitemid 36266774)
22. Martinsson L, Yang X, Beck O, et al. Pharmacokinetics of dexamphetamine in acute stroke. Clin Neuropharmacol. 2003;26:270-276. (Pubitemid 37221639)
23. Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int. 2004;142:101-113. (Pubitemid 38686542)
24. Pilgrim JL, Gerostamoulos D, Drummer OH, et al. Involvement of amphetamines in sudden and unexpected death. J Forensic Sci. 2009;54:478-485.